Active Ingredient: INOTERSEN SODIUM
Proprietary Name: TEGSEDI
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N211172
Product Number: 001
Approval Date: Oct 5, 2018
Applicant Holder Full Name: AKCEA THERAPEUTICS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
